Proto Labs Inc: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 23, 2018 and accepted by EDGAR at Feb 23, 2018, 15:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $150.6m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2017-01-01 to 2017-12-31 | $193.8m | us-gaap:GrossProfit |
| Research and development | 12 months2017-01-01 to 2017-12-31 | $23.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2017-01-01 to 2017-12-31 | $72.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $22.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2017-01-01 to 2017-12-31 | $51.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $1.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $1.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 26,845,071 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $81.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $32.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $4.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $36.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $165.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $518.7m | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $43.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $57.5m | us-gaap:Liabilities |
| Short-term borrowings | At period end2017-12-31 | $5.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-12-31 | $461.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-18-003222. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.